Only a handful of places left for our September 2026 cohort. Applications close soonApply now →

MSTA
Your future
starts here.

IMAGE Skincare

Also known as: Image Skincare, IMAGE MD

IMAGE Skincare is a professional skincare brand offering cleansers, moisturisers, sunscreens, serums and professional treatments. Its collections address concerns such as dryness, uneven tone, blemishes and visible ageing. Suitability and evidence are assessed for each product, not simply for the brand name.

In plain English — IMAGE Skincare is a brand of products used in home skincare and professional skin treatments. Some of its finished products have shown improvements in small, uncontrolled studies, so those findings apply to the products studied rather than the whole range. Choosing a product means matching its ingredients and instructions to the person's skin and medical history.

Evidence status

Manufacturer-supported

Published uncontrolled studies report improvements with a four-product IMAGE MD regimen and with Vol.U.Lift used alongside sunscreen after substantial weight loss. The studies used different populations and outcomes, and both involved commercial support. These observations inform assessment of the studied preparations rather than establishing effects throughout the range.

What IMAGE Skincare is#

IMAGE Skincare is a professional skincare brand spanning daily home care and therapist- or clinician-led treatments. Its range includes cleansing, moisturising, sun-protection and targeted products, alongside professional facials, enzyme peels and chemical peels.[4, 10]

The brand organises several collections by their intended cosmetic concern:

CollectionManufacturer’s positioning
VITAL CHydration and brightness
AGELESSVisible ageing, tone and texture
DAILY PREVENTIONSun protection
ILUMAUneven tone
CLEAR CELLOily and blemish-prone skin

These are product-family descriptions from the brand, not comparative rankings or diagnoses. IMAGE MD is another branded collection, including the regimen examined below.[4][6]

MidOcean Partners currently lists IMAGE Skincare as a portfolio company. The UK website’s legal terms identify Image Skincare UK Limited, company 10280941, as its operator; Companies House records that company as active. The named role here is website operator.[1, 2, 3]

The subject here is the brand and its finished-product evidence. Retinoids, sunscreen/SPF and the chemical-peel guide explain the ingredient or procedure questions in greater depth.

Use of IMAGE Skincare in aesthetic practice#

The practical starting point is a defined concern and the client’s current routine. A moisturiser, a sunscreen, a retinol preparation and a professional peel serve different purposes. Identify the exact preparation and agree what will be reviewed—for example, comfort, visible uneven tone or a particular skin measurement. Record concurrent prescribed treatments and previous product reactions.[4, 5, 6, 7]i[10]

For products supplied as cosmetics in Great Britain—England, Scotland and Wales—the applicable framework includes a Responsible Person, product safety documentation, substantiated claims, labelling and notification. Professional-use cosmetics are included. Northern Ireland follows the EU cosmetics framework and its Responsible Person/CPNP route, with specific provisions for qualifying NI goods entering GB. Check the requirements applicable to the actual supply route.[11][12]

The brand offers professional training and treatment support. Selection of a professional peel still requires the particular product’s instructions and a practitioner working within their competence; no peel or combined-active protocol is supplied here.[4, 10]

Contraindications and cautions#

Known allergy excludes a preparation containing the relevant allergen. Check its current ingredient list rather than relying on a collection name. A history of persistent product-related dermatitis needs appropriate medical assessment.[5, 13]i

Pregnancy and medical treatment require product-specific advice. The brand directs these clients to their healthcare professional. That precaution does not establish reproductive safety for every formula. Retinol-containing products warrant particular attention to the advice covering that product and the person’s circumstances.[5][8]

For currently irritated skin or a previous significant reaction, establish the cause before introducing another targeted product or professional treatment. Consider the whole routine and planned procedures when assessing suitability.[5, 13]

Clinical uses and the evidence behind them#

IMAGE MD: facial surface appearance

Henseler’s three-month uncontrolled study examined a four-product facial regimen including cleanser, serum, repair preparation and SPF50. Twenty-five women started and 19 returned for follow-up; completers were aged 39–68, with mean age 56. Standardised VISIA imaging showed the clearest favourable changes in red areas and brown spots. Wrinkle and porphyrin measurements did not show comparable improvement.[6]

This was an exploratory, multi-measure before–after study of the complete regimen, with previous skincare stopped and no comparison group. Products were supplied through Dr Marc Ronert; the author declared no competing interests and stated that the companies did not influence the conduct, analysis or publication. The observations support further assessment of that regimen and its measured outcomes.[6]i

Vol.U.Lift after substantial weight loss

A 12-week, single-arm Sacramento study enrolled 33 adults, of whom 29 completed. Eligibility was age 35–65 after self-reported loss of at least 10% of body weight in the preceding year; enrolled mean age was 49, and 31 participants were women. Weight-loss routes included medicines, bariatric surgery and other approaches. Participants used Vol.U.Lift with SPF75, covering the face, neck and jawline.[7]

The authors reported improvements in wrinkle grading, hydration, elasticity, transepidermal water loss and ultrasound-measured combined skin/subcutaneous thickness. Without a comparator, and with sunscreen also supplied, the study cannot isolate the cream’s causal contribution. IMAGE funded the study; senior author Sivamani disclosed other commercial consulting/speaking relationships. These are encouraging product-specific observations in the population studied.[7][7]i

Selecting an IMAGE Skincare product#

Match the preparation to the assessed concern, the client’s preferences and their ability to follow its instructions. Confirm the full product name, ingredients, current labelling and whether it is home care or a professional treatment. A study of an older multi-product regimen should be matched carefully to the preparation now being considered.[4, 5, 6, 7]i[6, 7, 8]i[10]

For sun protection, use the actual product’s protection labelling and directions. For retinol or another targeted active, review the existing routine and prescribed products before recommending an addition. Agree a clear outcome and review point rather than judging progress from the number of products used.[4, 5, 8]

The hyperpigmentation entry explains assessment of uneven pigmentation; a collection positioned for uneven tone is only one part of product selection, after the concern has been identified.

Adverse effects and their management#

Topical cosmetics can cause irritant or allergic contact dermatitis, with itching, dryness, cracking or blistering and changes in skin colour. If a preparation is suspected, avoid further exposure while the reaction is assessed. Persistent, recurrent or severe symptoms require medical review.[13]

In the Vol.U.Lift study, the authors reported no treatment-related adverse events, while tolerability questionnaires recorded some itching, burning, stinging or redness during follow-up. The two reporting categories should be kept distinct when discussing that study’s tolerability.[7]

Record the product, batch where available, timing, concurrent products and symptoms. IMAGE provides an adverse-reaction reporting route; applicable serious undesirable-effect reporting duties should also be followed. Reporting to a supplier does not replace necessary healthcare assessment.[5, 11, 13]i

Referral and scope boundaries#

Persistent or recurrent suspected cosmetic dermatitis may need assessment of the cause, including specialist investigation when it remains unclear. A skincare professional can provide an accurate exposure history; the medical diagnosis belongs with the relevant healthcare professional.[13]

For acne, NICE referral considerations include diagnostic uncertainty, nodulocystic disease, scarring, persistent pigment change and significant psychological distress. Those findings call for the appropriate care pathway rather than selection by a blemish-care label alone.[14, 4]i

A client considering Vol.U.Lift while undergoing weight-loss treatment should discuss medical-treatment questions with their treating professional. The brand’s general advice is to seek healthcare guidance when undergoing medical treatment.[5]

Mechanism of action#

IMAGE is a brand, so its formulations have different intended functions. Ingredient-level explanation should start with the actual preparation. The current Vol.U.Lift list includes glycerin, squalane, hyaluronic acid, bakuchiol and ornithine, while the cited AGELESS repair crème lists retinol. The brand describes XOSM as an encapsulated antioxidant technology; that is its formulation rationale.[9][8]

The finished-product studies measure appearance and skin properties over time. They are useful for understanding what was observed with those preparations, while the hyaluronic-acid, squalane, bakuchiol and retinoid references address their respective ingredient biology.[6, 7, 8, 9]

Commonly misstated claims#

A complex percentage read as pure retinol

Claim heard:“The AGELESS 0.3% retinol-complex crème contains 0.3% pure retinol.”

Literature finding: The current product page describes its complex as 0.1% retinoid plus 0.2% bakuchiol and lists retinol among the ingredients.[8]

Supported statement: Read the concentration description for the named formula; the complex percentage is not the stated pure-retinol percentage.

Software skin age read as biological reversal

Claim heard:“The IMAGE MD study proves that skin became 1.4 years younger.”

Literature finding:The imaging software’s mean age estimate fell by 1.4 years, but the change was not statistically significant, p=.165. The study measured an imaging estimate, not reversal of biological ageing.[6]i

Supported statement:The study’s clearest findings concerned red-area and brown-spot imaging measures, not proven reversal of skin age.

Tissue thickness read as restored facial fat

Claim heard:“The Vol.U.Lift study proves the cream restored lost facial fat.”

Literature finding:Although the product is promoted in facial-volume language, the study’s ultrasound endpoint combined skin and subcutaneous-tissue thickness. It did not directly measure newly formed fat cells in treated participants.[7]i[9]

Supported statement: The study reports appearance and tissue-thickness changes; these measurements alone do not prove restoration of lost facial fat.

Areas of remaining uncertainty#

  • Persistence after stopping: the retained studies examine defined treatment periods. Discuss review and ongoing cost without promising that improvement will remain after the regimen ends.[6, 7]
  • Transfer to a revised product:a current preparation may not be identical to a formulation in an older study. Keep the study’s product identity alongside the current ingredient list when discussing likely results.[6, 7, 8]i
  • The outcome that matters to the client:an imaging score, hydration measurement and the person’s experience answer different questions. Agree a visible or practical goal before using an instrument result to judge success.[6, 7]

Frequently asked questions#

Does every IMAGE product need to be used as a complete routine?

Selection is product- and person-specific. The IMAGE MD study examined a particular four-product regimen; that describes its research design rather than a universal requirement for every collection.[4, 5, 6]

Where can the full ingredient list be checked?

The brand directs customers to its product pages. Check the actual preparation and current supplied labelling when identifying ingredients relevant to allergy or suitability.[5, 11]

What should a client bring to a product consultation?

Their main concern, current skincare and prescribed treatments, previous reactions and any planned procedures. These details help assess a specific product rather than choosing from the brand name alone.[5, 13, 14]

References#

Each source is graded by evidence tier. Tier 4 material (manufacturer documents, expert consensus, practitioner experience) is useful for protocol and context, and is never presented as equivalent to independent clinical evidence.

  1. MidOcean Partners. IMAGE Skincare portfolio record. Accessed 16 September 2026.Tier 4Supports: Current investor portfolio status and August 2015 investment date; not a verified ownership percentage.Funding / interest: Commercial primary source published by the investor; not clinical evidence.
  2. IMAGE Skincare UK. Terms of use. Last updated June 2019; accessed 16 September 2026.Tier 4Supports: Names Image Skincare UK Limited, company 10280941, as website operator. Does not establish exclusive distribution or ultimate brand ownership.Funding / interest: Commercial website's own legal terms. Older address and geographical-availability wording are not used as current facts.
  3. Companies House. Image Skincare UK Limited, company 10280941. Company overview accessed 16 September 2026.Tier 1Supports: Active registered company identity matching the website terms; not product approval or proof of the international brand's ultimate ownership.Funding / interest: Official public corporate record; not a clinical study.
  4. IMAGE Skincare UK. The IMAGE Skincare advantage. Current collections and professional-channel description, accessed 16 September 2026.Tier 4Supports: Product families, manufacturer-advertised concerns, home/professional channel and training/support offer.Funding / interest: Manufacturer/brand marketing material; collection positioning is not independent efficacy evidence.
  5. IMAGE Skincare UK. Frequently asked questions. Accessed 16 September 2026.Tier 4Supports: Ingredient-list access, pregnancy/medical-treatment advice, ingredient-allergy precautions and adverse-reaction reporting route.Funding / interest: Brand-authored customer information; no independent pregnancy or allergy-safety trial supplied.
  6. Henseler H. Measurement of the effects of the IMAGE MD skin care regimen on skin surface features via modern imaging technology with the Visia complexion analysis camera system. GMS Interdiscip Plast Reconstr Surg DGPW. 2022;11:Doc09. doi:10.3205/iprs000170. PMID:36567877.Tier 3Supports: Uncontrolled three-month facial four-product regimen; 25 women started, 19 completed, completers aged 39–68; strongest imaging changes in red areas/brown spots, exploratory comparisons and nonsignificant software skin-age change.Funding / interest: Products supplied through Dr Marc Ronert, acknowledged in the paper. Author declared no competing interests and stated companies had no influence on conduct, analysis or publication. Product provision remains commercial support; separate monetary funding was not established.
  7. Nguyen N, Aguilar A, Afzal N, Lee A, Akram W, Duong MN, Sivamani RK. Topical Volumizing Cream Improves Facial Volume and Skin Health in Adults With Rapid Weight Loss From Pharmacologic (GLP-1/GIP Agonists), Surgical, or Behavioral Interventions. J Cosmet Dermatol. 2026;25(1):e70681. doi:10.1111/jocd.70681. PMID:41556403.Tier 3Supports: Twelve-week single-arm study, 33 enrolled/29 completed, Sacramento adults aged 35–65 eligible after self-reported substantial weight loss; Vol.U.Lift plus SPF75, face/neck/jawline; cosmetic and biophysical findings, tolerability, combined skin/subcutaneous-thickness endpoint.Funding / interest: IMAGE Skincare funded the study. Sivamani disclosed consultant/speaker relationships with multiple commercial companies; the other authors declared no conflicts. The disclosed outside-relationship list is retained in the research note and does not identify a personal IMAGE consultancy.
  8. IMAGE Skincare UK. AGELESS retinol repair creme 0.3% retinol complex. Product page and ingredient list, accessed 16 September 2026.Tier 4Supports: Current advertised cosmetic purpose, listed retinol and manufacturer description of 0.3% complex as 0.1% retinoid plus 0.2% bakuchiol. Unretrieved clinical-on-file percentages are not used.Funding / interest: Commercial product description. Test-report attribution in page footnotes is not independently resolved.
  9. IMAGE Skincare UK. Vol.U.Lift product page, ingredients and FAQ. Accessed 16 September 2026.Tier 4Supports: Current topical-product positioning after weight loss, listed ingredients, proprietary XOSM description and the facial-volume claim compared with the original study's measured endpoint.Funding / interest: Brand-authored marketing material; not an independent replication of its funded clinical study.
  10. IMAGE Skincare UK. Skincare treatments. Accessed 16 September 2026.Tier 4Supports: Professional facials, enzyme peels and chemical peels are offered; advertised benefits are manufacturer statements.Funding / interest: Commercial treatment catalogue, not comparative clinical evidence.
  11. Office for Product Safety and Standards / Department for Business and Trade. Making cosmetic products available to consumers in Great Britain. Published 4 October 2021; accessed 16 September 2026.Tier 1Supports: GB cosmetic-product safety, Responsible Person, product information, notification, labelling, claim-substantiation and serious undesirable-effect duties, including professional-use products.Funding / interest: Official government guidance; does not certify compliance of an individual IMAGE product.
  12. Office for Product Safety and Standards. Regulation 2009/1223 and the Cosmetic Products Enforcement Regulations 2013: Northern Ireland. Page updated 29 June 2026; paragraphs 1–40 read.Tier 1Supports: NI EU-cosmetics framework, NI/EEA Responsible Person and CPNP notification, with qualifying-NI-goods provisions; not GB-only requirements applied to all UK nations.Funding / interest: Official government guidance; no commercial sponsor.
  13. NHS. Contact dermatitis. Page reviewed 3 May 2023; accessed 16 September 2026.Tier 4Supports: Irritant/allergic cosmetic reactions, avoiding the causative substance, and medical assessment of persistent, recurrent or severe symptoms. Public patient information, not a formal evidence-graded guideline.Funding / interest: NHS public information; no commercial sponsor identified.
  14. National Institute for Health and Care Excellence. Acne vulgaris: management. NG198 recommendations, particularly sections 1.2 and 1.4. Last updated 3 August 2026; accessed 16 September 2026.Tier 1Supports: Acne assessment/referral for uncertainty, nodulocystic disease, scarring, persistent pigment change and significant psychological distress.Funding / interest: Publicly developed NICE guideline; not brand-sponsored product research.